Literature DB >> 1695449

Increased urinary excretion of the histamine metabolite N tau-methylhistamine during acetylsalicylic acid provocation in chronic urticaria patients.

E Oosting1, S H Kardaun, H M Doeglas, P Los, J G de Monchy.   

Abstract

Seventeen chronic urticaria patients with a history suggestive of acetylsalicylic acid (ASA, Aspirin)-intolerance were challenged with ASA; only 2 patients showed marked clinical reactions. These clinical reactions were accompanied by a significant increase in the urinary excretion of the most important histamine metabolite, N tau-methylhistamine, in comparison with 15 non-responders (p less than or equal to 0.05) and placebo test. These results suggest an involvement of histamine in the pathogenesis of ASA-intolerance in chronic urticaria patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695449     DOI: 10.1007/bf01969053

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  10 in total

1.  Plasma level of histamine in aspirin-sensitive urticaria.

Authors:  S I Asad; R Murdoch; L J Youlten; M H Lessof
Journal:  Ann Allergy       Date:  1987-09

Review 2.  Proposed mechanisms of aspirin sensitivity reactions.

Authors:  D D Stevenson; R A Lewis
Journal:  J Allergy Clin Immunol       Date:  1987-12       Impact factor: 10.793

3.  Improved diagnosis of mastocytosis by measurement of urinary histamine metabolites.

Authors:  J J Keyzer; J G de Monchy; J J van Doormaal; P C van Voorst Vader
Journal:  N Engl J Med       Date:  1983-12-29       Impact factor: 91.245

4.  Correlation between urinary levels of histamine metabolites in 24-hour urine and morning urine samples of man: influence of histamine-rich food.

Authors:  E Oosting; J J Keyzer; B G Wolthers
Journal:  Agents Actions       Date:  1989-04

5.  Oral aspirin challenges in asthmatic patients: a study of plasma histamine.

Authors:  D D Stevenson; C M Arroyave; K N Bhat; E M Tan
Journal:  Clin Allergy       Date:  1976-09

6.  Aspirin desensitization in aspirin-sensitive asthmatic patients: clinical manifestations and characterization of the refractory period.

Authors:  W W Pleskow; D D Stevenson; D A Mathison; R A Simon; M Schatz; R S Zeiger
Journal:  J Allergy Clin Immunol       Date:  1982-01       Impact factor: 10.793

7.  Histamine metabolism after adverse reactions due to d-tubocurarine administration.

Authors:  E Oosting; F J Richardson; J J Keyzer; B G Wolthers; S Agoston; D Langrehr
Journal:  Agents Actions       Date:  1987-06

8.  Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.

Authors:  L B Schwartz; D D Metcalfe; J S Miller; H Earl; T Sullivan
Journal:  N Engl J Med       Date:  1987-06-25       Impact factor: 91.245

Review 9.  Aspirin and allergic diseases: a review.

Authors:  G A Settipane
Journal:  Am J Med       Date:  1983-06-14       Impact factor: 4.965

10.  Age dependent normal values of histamine and histamine metabolites in human urine.

Authors:  E Oosting; J J Keyzer; B G Wolthers; R J Scholtis
Journal:  Agents Actions       Date:  1988-04
  10 in total
  1 in total

1.  Pathogenic Mechanisms and In Vitro Diagnosis of AERD.

Authors:  Dirk Schäfer; Steffen Maune
Journal:  J Allergy (Cairo)       Date:  2012-05-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.